Shanxi C&Y Pharmaceutical Group Co Ltd Asset Resilience Ratio

Latest as of September 2020: 0.26%

Shanxi C&Y Pharmaceutical Group Co Ltd asset resilience ratio. Shanxi C&Y Pharmaceutical Group Co Ltd (300254) has an Asset Resilience Ratio of 0.26% as of September 2020. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Shanxi C&Y Pharmaceutical Group Co Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥5.00 Million

≈ $731.66K USD Cash + Short-term Investments

Total Assets

CN¥1.91 Billion

≈ $279.34 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Shanxi C&Y Pharmaceutical Group Co Ltd (2013–2014)

Asset resilience ratio of Shanxi C&Y Pharmaceutical Group Co Ltd from 2013 to 2014. This chart shows how Shanxi C&Y Pharmaceutical Group Co Ltd's Asset Resilience Ratio has changed over time. Read Shanxi C&Y Pharmaceutical Group Co Ltd (300254) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Shanxi C&Y Pharmaceutical Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Shanxi C&Y Pharmaceutical Group Co Ltd (300254) total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥5.00 Million	0.26%
Total Liquid Assets	CN¥5.00 Million	0.26%

Asset Resilience Insights

Limited Liquidity: Shanxi C&Y Pharmaceutical Group Co Ltd maintains only 0.26% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shanxi C&Y Pharmaceutical Group Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shanxi C&Y Pharmaceutical Group Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	7.89%
H Lundbeck A/S CO:HLUN-B	Drug Manufacturers - Specialty & Generic	-0.56%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Viyash Scientific Limited NSE:SEQUENT	Drug Manufacturers - Specialty & Generic	0.08%
Anhui Fengyuan Pharmaceutical Co Ltd SHE:000153	Drug Manufacturers - Specialty & Generic	1.81%

Shanxi C&Y Pharmaceutical Group Co Ltd Asset Resilience Ratio by Year (2013–2014)

Shanxi C&Y Pharmaceutical Group Co Ltd asset resilience ratio by year from 2013 to 2014. The table below shows the annual Asset Resilience Ratio data for Shanxi C&Y Pharmaceutical Group Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2014-12-31	1.84%	CN¥21.76 Million ≈ $3.18 Million	CN¥1.18 Billion ≈ $172.87 Million	+1.81pp
2013-12-31	0.04%	CN¥388.94K ≈ $56.91K	CN¥1.09 Billion ≈ $159.56 Million	--

pp = percentage points

About Shanxi C&Y Pharmaceutical Group Co Ltd

SHE:300254 China Drug Manufacturers - Specialty & Generic

Market Cap

$283.41 Million

CN¥1.94 Billion CNY

Market Cap Rank

#14833 Global

#4355 in China

Share Price

CN¥7.53

Change (1 day)

+2.59%

52-Week Range

CN¥7.27 - CN¥14.68

All Time High

CN¥31.09